ROCK-KINASE-INHIBITOREN

Patent europeic · EP3877364 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3877364
Numer da la dumonda
EP19881800
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
06-11-2019
Publitgà
15-09-2021
Concedì
21-08-2024
La protecziun finescha il pli tard
05-11-2039
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
C07D 217/02 (2006.01)
C07D 217/24 (2006.01)
C07D 405/06 (2006.01)
A61K 31/4725 (2006.01)
A61P 9/00 (2006.01)
Prioritad
US 201862756202 P 06.11.2018
Dumonda PCT
PCT/US2019/059992 06.11.2019
Publicaziun PCT
WO2020/097158 14.05.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 02-07-2025

    Midada

    Published in Swissreg on 02.07.2025

  3. 09-01-2025

    Midada

    Published in Swissreg on 09.01.2025

  4. 21-10-2024

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 21.10.2024

  5. 21-08-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.08.2024

Partidas

Possessur

Cervello Therapeutics, LLC

325 Technology Drive, Malvern PA 19355, US

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

VARANO, Anthony, Joseph

Berwyn, PA 19312, US

LEE, Matthew, Randolph

Del Mar, CA 92014, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.